SCHEMBL4248322

SCHEMBL4248322

CS(=O)(=O)c1cccc(NC(=O)c2cccc3[nH]c(C(N)=O)nc23)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.53
RXFP1 Q9HBX9 2/20 0.50
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
LMNA P02545 1/20 0.46
PARP1 P09874 4/20 0.45
DHODH Q02127 1/20 0.45
ALDH1A1 P00352 2/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
KDM4E B2RXH2 1/20 0.43
PRKDC P78527 1/20 0.42
ATM Q13315 1/20 0.42
ATR Q13535 1/20 0.42
BRAF P15056 1/20 0.42
PLK4 O00444 1/20 0.42
ROCK2 O75116 1/20 0.42
MAP4K4 O95819 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4248326 0.87 CSNK2A1 (0.55) CSNK2A1RXFP1MEN1KMT2ALMNA
SCHEMBL4246148 0.79 CHEK2 (0.53) RXFP1LMNADHODHALDH1A1BRAF
SCHEMBL4239537 0.78 AURKA (0.49) PARP1CA1CA2RPS6KB1MAPK9
SCHEMBL4238070 0.78 PARP1 (0.46) PARP1ALDH1A1KDM4E
SCHEMBL4246266 0.78 PKN1 (0.53) MEN1KMT2ALMNAPARP1DHODH
SCHEMBL4244333 0.78 PARP1 (0.48) MEN1KMT2ALMNAPARP1DHODH
SCHEMBL4238204 0.77 MAOB (0.60) CSNK2A1ROCK2MAP4K4RPS6KB1CLK2
SCHEMBL1201422 0.76 CSNK2A1 (0.48) CSNK2A1RXFP1MEN1KMT2AALDH1A1
SCHEMBL4235724 0.76 IMPDH2 (0.47) PARP1PLK4ROCK2MAP4K4PIM1
SCHEMBL4239814 0.76 PARP1 (0.46) RXFP1PARP1DHODHATMAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946259-B2 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors HIGH POINT PHARMACEUTICALS, LLC (US) 2015-02-03 US disclosed
US-20140066477-A1 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors HIGH POINT PHARMACEUTICALS, LLC (US) 2014-03-06 US disclosed
US-8598353-B2 Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors HIGH POINT PHARMACEUTICALS, LLC (US) 2013-12-03 US disclosed
EP-2457901-A1 Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors High Point Pharmaceuticals, LLC (US) 2012-05-30 EP disclosed
US-20090326006-A1 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors VTVX HOLDINGS II LLC 2009-12-31 US disclosed
US-20060223849-A1 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors HIGH POINT PHARMACEUTICALS, LLC 2006-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326006-A1 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors BACE1, BACE2, APP CSNK2A1 1404/4885RXFP1 4757/4885MEN1 2918/4885
US-20060223849-A1 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors BACE1, BACE2, APP CSNK2A1 1404/4885RXFP1 4757/4885MEN1 2918/4885
US-20140066477-A1 Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors BACE1, BACE2, APP CSNK2A1 1404/4885RXFP1 4757/4885MEN1 2918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.